Completion of the clinical trial of PacePress® with 122 patients
August 19, 2025
Medinice S.A. has completed the clinical trial of its innovative device PacePress® with a positive outcome of the final analysis.
The study was conducted in Poland in six clinical centers with 122 patients, under a randomized protocol. Participants were randomly assigned to two groups: one group used PacePress®, the other a standard dressing. The analysis showed the Medinice solution’s superiority in minimizing the risk of bleeding complications following CIED implantation. This is a breakthrough moment for the company - the first completed clinical trial in its history, and a key step towards commercializing the product.
Detailed information about the medical device PacePress® can be found under the following link:
Learn moreWe Care About Your Privacy
Medinice S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.